Speciality Medi.

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0R0M01014
  • NSEID:
  • BSEID: 544738
INR
148.00
0.00 (0.00%)
BSENSE

Sep 25, 10:33 AM

BSE+NSE Vol: 1000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 29.20% vs 111.71% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 49.85% vs 73.16% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 158.48% vs -17.20% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 81.11% vs 145.30% in Mar 2025

Compare Profit and Loss Results of Speciality Medi.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
75.00
36.00
39.00
108.33%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
75.00
36.00
39.00
108.33%
Expenditure (Ex Depriciation)
Stock Adjustments
-10.00
0.00
-10.00
0%
Raw Materials Consumed
65.00
33.00
32.00
96.97%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
1.00
0.00
1.00
0%
Operating Expenses
0.00
0.00
0.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
2.00
0.00
2.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
1.00
0.00
1.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
61.00
34.00
27.00
79.41%
Operating Profit (PBDIT) excl Other Income
13.00
2.00
11.00
550.00%
Other Income
0.00
0.00
0.00
0%
Operating Profit (PBDIT)
14.00
2.00
12.00
600.00%
Interest
1.00
0.00
1.00
0%
Profit before Depriciation and Tax
13.00
2.00
11.00
550.00%
Depreciation
0.00
0.00
0.00
0%
Profit Before Taxation & Exceptional Items
13.00
2.00
11.00
550.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
13.00
2.00
11.00
550.00%
Provision for Tax
0.00
0.00
0.00
0%
Profit After Tax
13.00
1.00
12.00
1,200.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
13.00
-8.00
21.00
262.50%
Profit Available for appropriations
26.00
-6.00
32.00
533.33%
Appropriations
26.00
-6.00
32.00
533.33%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
14.9
1.24
13.66
1,101.61%
Profit And Loss - Net Sales
Net Sales 75.29 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 29.20% vs 111.71% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 13.68 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 49.85% vs 73.16% in Mar 2025

Profit And Loss - Interest
Interest 1.32 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 158.48% vs -17.20% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 13.03 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 81.11% vs 145.30% in Mar 2025

Footer loading